AU3968595A - Conditional transformation of genetically engineered cells - Google Patents
Conditional transformation of genetically engineered cellsInfo
- Publication number
- AU3968595A AU3968595A AU39685/95A AU3968595A AU3968595A AU 3968595 A AU3968595 A AU 3968595A AU 39685/95 A AU39685/95 A AU 39685/95A AU 3968595 A AU3968595 A AU 3968595A AU 3968595 A AU3968595 A AU 3968595A
- Authority
- AU
- Australia
- Prior art keywords
- genetically engineered
- engineered cells
- conditional transformation
- conditional
- transformation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000009466 transformation Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
- C07K2319/715—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16 containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/72—Fusion polypeptide containing domain for protein-protein interaction containing SH2 domain
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32893194A | 1994-10-25 | 1994-10-25 | |
| US328931 | 1994-10-25 | ||
| PCT/US1995/013776 WO1996012796A1 (en) | 1994-10-25 | 1995-10-25 | Conditional transformation of genetically engineered cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3968595A true AU3968595A (en) | 1996-05-15 |
Family
ID=23283095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU39685/95A Abandoned AU3968595A (en) | 1994-10-25 | 1995-10-25 | Conditional transformation of genetically engineered cells |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0785992A4 (de) |
| JP (1) | JPH11511643A (de) |
| AU (1) | AU3968595A (de) |
| WO (1) | WO1996012796A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1045702T3 (da) * | 1998-01-08 | 2008-07-14 | Univ Washington | Fremgangsmåder til styring af celledifferentiering og -vækst ved anvendelse af et fusionsprotein og et lægemiddel |
| ES2347027T3 (es) | 1998-05-22 | 2010-10-22 | The Board Of Trustees Of The Leland Stanford Junior University | Moleculas bifuncionales y terapias basadas en las mismas. |
| AU2044001A (en) | 1999-11-19 | 2001-05-30 | Board Of Trustees Of The Leland Stanford Junior University | Targeted bifunctional molecules and therapies based thereon |
| US7220552B1 (en) | 1999-11-19 | 2007-05-22 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and their use in the disruption of protein-protein interactions |
| US6887842B1 (en) | 1999-11-19 | 2005-05-03 | The Board Of Trustees Of The Leland Stanford Junior University | Modulating a pharmacokinetic property of a drug by administering a bifunctional molecule containing the drug |
| DK1402015T3 (da) | 2001-06-22 | 2011-12-05 | Hoffmann La Roche | Opløseligt kompleks omfattende et retroviralt overfladeglycoprotein og FkpA eller SlyD |
| CA2516320C (en) | 2003-02-18 | 2015-05-26 | Kevin Slawin | Induced activation in dendritic cells |
| CA2666667C (en) | 2006-10-19 | 2023-06-20 | Baylor College Of Medicine | Generating an immune response by inducing cd40 and pattern recognition receptors |
| EP2331680B1 (de) | 2008-09-22 | 2017-05-03 | Baylor College Of Medicine | Verfahren und zusammensetzungen zur erzeugung einer immunreaktion mittels cd40-induktion sowie strukturerkennungsrezeptoradaptern |
| WO2011146862A1 (en) | 2010-05-21 | 2011-11-24 | Bellicum Pharmaceuticals, Inc. | Methods for inducing selective apoptosis |
| US10634668B2 (en) | 2012-09-13 | 2020-04-28 | Takara Bio Usa, Inc. | Modifiable chemical inducers of proximity and methods of using the same |
| US9434935B2 (en) | 2013-03-10 | 2016-09-06 | Bellicum Pharmaceuticals, Inc. | Modified caspase polypeptides and uses thereof |
| WO2014151960A2 (en) | 2013-03-14 | 2014-09-25 | Bellicum Pharmaceuticals, Inc. | Methods for controlling t cell proliferation |
| CA2912172A1 (en) | 2013-06-05 | 2014-12-11 | Bellicum Pharmaceuticals, Inc. | Methods for inducing partial apoptosis using caspase polypeptides |
| US9593356B2 (en) | 2013-06-11 | 2017-03-14 | Takara Bio Usa, Inc. | Protein enriched microvesicles and methods of making and using the same |
| US10934346B2 (en) | 2014-02-14 | 2021-03-02 | Bellicum Pharmaceuticals, Inc. | Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12 |
| US10888608B2 (en) | 2014-09-02 | 2021-01-12 | Bellicum Pharmaceuticals, Inc. | Costimulation of chimeric antigen receptors by MyD88 and CD40 polypeptides |
| ES2904301T3 (es) | 2014-11-03 | 2022-04-04 | Academisch Ziekenhuis Leiden H O D N Leids Univ Medisch Centrum | Receptores de células T dirigidos contra Bob1 y usos de los mismos |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0642585T3 (da) * | 1992-05-18 | 2006-05-15 | Genentech Inc | Aktiviering af oligomeriserende receptorer ved anvendelse af fusionerede receptorligander |
| CZ206195A3 (en) * | 1993-02-12 | 1996-04-17 | Univ Leland Stanford Junior | Controlled transcription of target genes and other biological materials |
| HUT73100A (en) * | 1993-07-16 | 1996-06-28 | Harvard College | Regulated apoptosis |
| AU3409295A (en) * | 1994-08-18 | 1996-03-14 | Ariad Gene Therapeutics, Inc. | Regulatable elimination of gene expression, gene product function and engineered host cells |
-
1995
- 1995-10-25 JP JP8514133A patent/JPH11511643A/ja active Granted
- 1995-10-25 WO PCT/US1995/013776 patent/WO1996012796A1/en not_active Ceased
- 1995-10-25 AU AU39685/95A patent/AU3968595A/en not_active Abandoned
- 1995-10-25 EP EP95937629A patent/EP0785992A4/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP0785992A4 (de) | 1999-12-22 |
| EP0785992A1 (de) | 1997-07-30 |
| WO1996012796A1 (en) | 1996-05-02 |
| JPH11511643A (ja) | 1999-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3968595A (en) | Conditional transformation of genetically engineered cells | |
| AU6722296A (en) | Seed-blanket reactors | |
| AU6725694A (en) | Power coupling | |
| AU6347394A (en) | Aplha-heteroaryloxymethyl ketones as interleukin-1beta converting enzyme inhibitors | |
| AU6096496A (en) | Allogeneic and xenogeneic transplantation | |
| AU6267694A (en) | High active enzyme granulates | |
| AU3478193A (en) | Genetically engineered endothelial cells | |
| AU3833297A (en) | Fabrication process of solar cell | |
| AU2956092A (en) | Novel plant gene | |
| AU5131493A (en) | Improved semiconductor architecture and application therefor | |
| AU3491195A (en) | Genetically engineered cells that produce dopamine | |
| AU3243595A (en) | Genetically engineered swine cells | |
| AU2032397A (en) | Biodecontamination reactor | |
| AU6587596A (en) | Culture vessel and assembly | |
| AU1830195A (en) | Prostatic growth factor | |
| AU1274697A (en) | Improved plant shelter | |
| GB2303881B (en) | Inchworm type of actuator | |
| AU3752293A (en) | Photovoltaic cells | |
| AU3591597A (en) | Transformation and genetherapy of cells of the inner ear | |
| AU2682895A (en) | EG Cells of Ungulates | |
| AU6809698A (en) | Waterproof structure of cases | |
| AUPO776697A0 (en) | Method of increasing the iron content of plant cells | |
| AU4714497A (en) | Handling of mushrooms | |
| AU9008998A (en) | Sea-wave power plant | |
| AU6853498A (en) | Flutamide preparations and method for manufacturing the same |